Supplementary Table S3 from Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer

Supplementary Table S3 from Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer

<p>Multivariable Cox proportional hazards models for time to progression and time to death</p>

Kaydedildi:
Detaylı Bibliyografya
Yazar: Sofie H. Tolmeijer (15313251) (author)
Diğer Yazarlar: Emmy Boerrigter (15313254) (author), Takayuki Sumiyoshi (15034119) (author), Edmond M. Kwan (15313257) (author), Sarah W.S. Ng (14960841) (author), Matti Annala (15313260) (author), Gráinne Donnellan (15313263) (author), Cameron Herberts (14960820) (author), Guillemette E. Benoist (15313266) (author), Paul Hamberg (15313269) (author), Diederik M. Somford (15035198) (author), Inge M. van Oort (15035171) (author), Jack A. Schalken (15313272) (author), Niven Mehra (15011036) (author), Nielka P. van Erp (15313275) (author), Alexander W. Wyatt (14960922) (author)
Baskı/Yayın Bilgisi: 2025
Konular:
Cancer
Cancer Detection and Diagnosis
Methods and Technology
Biomarkers
Circulating tumor cells/DNA/exosomes
Genitourinary Cancers
Prostate cancer
Liquid Biopsy
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
Diğer Bilgiler
Özet:<p>Multivariable Cox proportional hazards models for time to progression and time to death</p>

Benzer Materyaller